Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The National Lung Matrix Trial of personalized therapy in lung cancer. | Nature | 2020 | 32669708 | PubTator, text mining | PubMed |
| Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to Therapy. | Int J Mol Sci | 2020 | 32668761 | PubTator, text mining | PubMed |
| Molecular Protein and Expression Profile in the Primary Tumors of Clear Cell Renal Carcinoma and Metastases. | Cells | 2020 | 32668608 | PubTator, text mining | PubMed |
| Analysis of the concordance of 20 immunohistochemical tissue markers in metastasectomy lesions in patients with metastatic renal cell carcinoma: A retrospective study using tissue microarray. | Investig Clin Urol | 2020 | 32665993 | PubTator, text mining | PubMed |
| Molecular profiling and analysis of genetic aberrations aimed at identifying potential therapeutic targets in fibrolamellar carcinoma of the liver. | Cancer | 2020 | 32663328 | PubTator, text mining | PubMed |
| Activation of CD8+ T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors. | Cancer Immunol Res | 2020 | 32661093 | PubTator, text mining | PubMed |
| Combined blockade of EGFR and glutamine metabolism in preclinical models of colorectal cancer. | Transl Oncol | 2020 | 32652471 | PubTator, text mining | PubMed |
| Measurement of autophagy flux in benign prostatic hyperplasia in vitro. | Prostate Int | 2020 | 32647643 | PubTator, text mining | PubMed |
| A Phase I Study of Ribociclib Plus Everolimus in Patients with Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy. | J Pancreat Cancer | 2020 | 32642630 | PubTator, text mining | PubMed |
| MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC. | JCI Insight | 2020 | 32634121 | PubTator, text mining | PubMed |
| PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer. | Cell Death Dis | 2020 | 32632098 | PubTator, text mining | PubMed |
| IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers. | Cancers (Basel) | 2020 | 32630797 | PubTator, text mining | PubMed |
| mTORC1 and mTORC2 expression in inner retinal neurons and glial cells. | Exp Eye Res | 2020 | 32622801 | PubTator, text mining | PubMed |
| Systematic quantitative analysis of ribosome inventory during nutrient stress. | Nature | 2020 | 32612236 | PubTator, text mining | PubMed |
| mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer. | Yonsei Med J | 2020 | 32608200 | PubTator, text mining | PubMed |
| Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer: A Review. | Onco Targets Ther | 2020 | 32606799 | PubTator, text mining | PubMed |
| Coinhibition of activated p38 MAPKα and mTORC1 potentiates stemness maintenance of HSCs from SR1-expanded human cord blood CD34+ cells via inhibition of senescence. | Stem Cells Transl Med | 2020 | 32602209 | PubTator, text mining | PubMed |
| Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways. | Proc Natl Acad Sci U S A | 2020 | 32601199 | PubTator, text mining | PubMed |
| Down-Regulation of the Mammalian Target of Rapamycin (mTOR) Pathway Mediates the Effects of the Paeonol-Platinum(II) Complex in Human Thyroid Carcinoma Cells and Mouse SW1736 Tumor Xenografts. | Med Sci Monit | 2020 | 32594094 | PubTator, text mining | PubMed |
| TIPE1-mediated autophagy suppression promotes nasopharyngeal carcinoma cell proliferation via the AMPK/mTOR signalling pathway. | J Cell Mol Med | 2020 | 32588529 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=44